Daniel L Menichella - Chief Executive Officer, Kaleido Biosciences, Inc

As of September 2, 2021


Daniel L Menichella Net Worth

  • Net worth is estimated to be at least $354.77K
  • Owns at least 20,000 units of Kaleido Biosciences, Inc stock

Daniel L Menichella Compensation at Kaleido Biosciences, Inc in 2020

  • Earned a $118,731 salary
  • Received a total compensation of $3,946,827

Daniel L Menichella Trading

  • Largest purchase of shares was 20,000 units , worth over $230K on February 26, 2021
  • In total has made about 4 transactions over a year
  • Usually trades in September, February, October and March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Daniel L Menichella Mailing Address

  • Mailing address is 79 TW Alexander Drive 4101 Research Commons Research Triangle Park NC 27709 NC

Kaleido Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Daniel Menichella 2020 $118,731 - $3,777,318 $49,044 $1,734 $3,946,827
Daniel Menichella 2019 - - - - - -
William Duke, Jr. 2020 $420,000 $100,000 $527,067 $142,800 $10,069 $1,199,936
William Duke, Jr. 2019 $44,692 - $1,675,995 - $277 $1,720,964
Katharine Knobil, M.D. 2020 $450,000 $75,668 $805,820 $157,590 $12,524 $1,501,602
Katharine Knobil, M.D. 2019 $450,000 $200,000 $583,729 $170,252 $47,783 $1,451,764
Alison Lawton 2020 $515,000 - $351,745 $257,500 $11,323 $1,135,568
Alison Lawton 2019 $500,000 $250,000 $2,101,475 $276,563 $11,196 $3,139,234
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1751299/000156459021023638/kldo-def14a_20210614.htm

Kaleido Biosciences, Inc Insider Trading

  • The most recent transaction was 20,000 units bought on February 26, 2021 by Daniel L Menichella worth over $230K
  • In the last 2 years, insiders at Kaleido Biosciences, Inc bought an estimated value of $32.95M
  • The most active traders are Jerald Korn, General Counsel,  William Duke Jr., Chief Financial Officer,  and Alison Lawton, See Remarks
  • Insider trading is most common in July, with the busiest year in 2020

Kaleido Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1